Chevillard C, Mathieu M N, Recommis D
Br J Pharmacol. 1980;71(2):513-8. doi: 10.1111/j.1476-5381.1980.tb10965.x.
1 The effects of piribedil on contractile responses and noradrenaline release evoked by sympathetic nerve stimulation have been studied in the isolated kidney of the rabbit. These effects were compared to those of apomorphine.2 Electrical stimulation (2, 5 and 10 Hz) of sympathetic renal nerves produced frequency-dependent increases in perfusion pressure and noradrenaline release. Piribedil did not affect (0.1 mug/min) or diminished (1 and 10 mug/min) the stimulation-evoked increase in perfusion pressure, and increased noradrenaline release in a dose-dependent manner.3 Increases in renal perfusion pressure and noradrenaline release induced by electrical stimulation were decreased by apomorphine (0.1 and 1 mug/min). These inhibitory effects were more marked at low frequencies of stimulation and were prevented by haloperidol (0.2 mumol/1).4 Piribedil (0.1 and 1 mug/min) and apomorphine (0.1, 1 and 10 mug/min) did not affect the increases in renal perfusion pressure elicited by exogenously administered noradrenaline, but piribedil (10 mug/min) diminished them.5 In the presence of desipramine (0.5 mumol/l), piribedil (0.1, 1 and 10 mug/min) produced a dosedependent inhibition of the increases in renal perfusion pressure and noradrenaline release evoked by sympathetic nerve stimulation; the inhibitory effect of piribedil was more marked at low frequencies of stimulation and was prevented by haloperidol.6 Piribedil increased the resting release of noradrenaline from the rabbit kidney, in contrast to apomorphine, which was without effect.7 It is suggested that piribedil has a complex effect on sympathetic transmission. This drug exhibits an ;amphetamine-like' action, causing noradrenaline release from its postganglionic stores. This releasing effect masks an action on prejunctional inhibitory dopamine receptors. In addition, at high doses, piribedil exhibits a marked action on postjunctional sites, since it reduces the vasoconstrictor effect of exogenous noradrenaline.
已在兔离体肾脏中研究了吡贝地尔对交感神经刺激所诱发的收缩反应和去甲肾上腺素释放的影响。并将这些影响与阿扑吗啡的影响进行了比较。
对肾交感神经进行电刺激(2、5和10赫兹)会使灌注压和去甲肾上腺素释放呈频率依赖性增加。吡贝地尔(0.1微克/分钟)对刺激诱发的灌注压升高无影响或使其降低(1和10微克/分钟),并以剂量依赖性方式增加去甲肾上腺素释放。
阿扑吗啡(0.1和1微克/分钟)可降低电刺激所诱发的肾灌注压和去甲肾上腺素释放增加。这些抑制作用在低刺激频率时更为明显,并可被氟哌啶醇(0.2微摩尔/升)阻断。
吡贝地尔(0.1和1微克/分钟)和阿扑吗啡(0.1、1和10微克/分钟)对外源性给予去甲肾上腺素所引起的肾灌注压升高无影响,但吡贝地尔(10微克/分钟)可使其降低。
在存在地昔帕明(0.5微摩尔/升)的情况下,吡贝地尔(0.1、1和10微克/分钟)对交感神经刺激所诱发的肾灌注压和去甲肾上腺素释放增加产生剂量依赖性抑制;吡贝地尔的抑制作用在低刺激频率时更为明显,并可被氟哌啶醇阻断。
与无作用的阿扑吗啡相反,吡贝地尔增加了兔肾脏去甲肾上腺素的静息释放。
提示吡贝地尔对交感神经传递具有复杂作用。该药物表现出“类似苯丙胺”的作用,导致节后储存的去甲肾上腺素释放。这种释放作用掩盖了对节前抑制性多巴胺受体的作用。此外,高剂量时,吡贝地尔对节后位点有明显作用,因为它可降低外源性去甲肾上腺素的血管收缩作用。